Growth Metrics

Solid Biosciences (SLDB) Non-Current Assets: 2017-2023

Historic Non-Current Assets for Solid Biosciences (SLDB) over the last 7 years, with Dec 2023 value amounting to $35.2 million.

  • Solid Biosciences' Non-Current Assets fell 11.13% to $32.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $32.3 million, marking a year-over-year decrease of 11.13%. This contributed to the annual value of $35.2 million for FY2023, which is 13.32% down from last year.
  • Per Solid Biosciences' latest filing, its Non-Current Assets stood at $35.2 million for FY2023, which was down 13.32% from $40.6 million recorded in FY2022.
  • Over the past 5 years, Solid Biosciences' Non-Current Assets peaked at $40.6 million during FY2022, and registered a low of $9.8 million during FY2021.
  • Over the past 3 years, Solid Biosciences' median Non-Current Assets value was $35.2 million (recorded in 2023), while the average stood at $28.5 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first dropped by 28.55% in 2020, then surged by 315.79% in 2022.
  • Yearly analysis of 5 years shows Solid Biosciences' Non-Current Assets stood at $17.2 million in 2019, then decreased by 28.55% to $12.3 million in 2020, then declined by 20.38% to $9.8 million in 2021, then surged by 315.79% to $40.6 million in 2022, then fell by 13.32% to $35.2 million in 2023.